000061658 001__ 61658
000061658 005__ 20220120225831.0
000061658 0247_ $$2doi$$a10.1186/s12888-017-1301-7
000061658 0248_ $$2sideral$$a99087
000061658 037__ $$aART-2017-99087
000061658 041__ $$aeng
000061658 100__ $$aBecoña, E.
000061658 245__ $$aCognitive-behavioral treatment with behavioral activation for smokers with depressive symptomatology: Study protocol of a randomized controlled trial
000061658 260__ $$c2017
000061658 5060_ $$aAccess copy available to the general public$$fUnrestricted
000061658 5203_ $$aBackground: Smoking is an important risk factor for mental health-related problems. Numerous studies have supported a bi-directional association between cigarette smoking and depression. Despite the advances in understanding the comorbidity between both problems, the most effective psychological treatment that simultaneously targets smoking and depressive symptomatology remains unclear. The objective of this study is to assess the effectiveness of a cognitive-behavioral intervention for smoking cessation with components of behavioral activation for managing depressed mood. Method: A single blind, three-arm, superiority randomized controlled trial is proposed. Participants will be smokers over 18years old, who smoke at least 8 cigarettes per day. Participants will be randomized to one of three conditions, using a 2:2:1 allocation ratio: 1) standard cognitive-behavioral smoking cessation treatment; 2) standard cognitive-behavioral smoking cessation treatment plus behavioral activation; or 3) a three-month delayed treatment control group. The primary outcome measures will be biochemically verified point-prevalence abstinence (carbon monoxide in expired air) and significant change from baseline in depressive symptoms to the end of treatment, and at the 3-, 6-, and 12-month follow-up. Discussion: This study aims to assess the efficacy of a cognitive-behavioral intervention with behavioral activation components for smoking cessation and depressive symptoms, compared to a standard cognitive-behavioral intervention to quit smoking. As the relation between depressive symptoms, even at subclinical levels, and quitting smoking difficulties is well known, we expect that such intervention will allow obtaining higher abstinence rates, lower relapse rates, and mood improvement. Trial registration:ClinicalTrials.gov: NCT02844595. Retrospectively registered 19th July, 2016. The study started in January 2016, and the recruitment is ongoing.
000061658 536__ $$9info:eu-repo/grantAgreement/ES/MINECO/PSI2015-66755-R
000061658 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000061658 590__ $$a2.419$$b2017
000061658 591__ $$aPSYCHIATRY$$b71 / 142 = 0.5$$c2017$$dQ2$$eT2
000061658 592__ $$a1.346$$b2017
000061658 593__ $$aPsychiatry and Mental Health$$c2017$$dQ1
000061658 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000061658 700__ $$aMartínez-Vispo, C.
000061658 700__ $$aSenra, C.
000061658 700__ $$aLópez-Durán, A.
000061658 700__ $$aRodríguez-Cano, R.
000061658 700__ $$0(orcid)0000-0002-9645-8109$$aFernández Del Río, E.$$uUniversidad de Zaragoza
000061658 7102_ $$14009$$2740$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicología Social
000061658 773__ $$g17, 1 (2017), 134 [10pp]$$pBMC Psychiatry$$tBMC Psychiatry$$x1471-244X
000061658 8564_ $$s659927$$uhttps://zaguan.unizar.es/record/61658/files/texto_completo.pdf$$yVersión publicada
000061658 8564_ $$s81847$$uhttps://zaguan.unizar.es/record/61658/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000061658 909CO $$ooai:zaguan.unizar.es:61658$$particulos$$pdriver
000061658 951__ $$a2022-01-20-22:54:22
000061658 980__ $$aARTICLE